| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454676 | Lung Cancer | 2016 | 8 Pages |
Abstract
PD-L1 expression was higher in SC than in NSCLC as well as immune-cell infiltration by TCD3 cells and macrophages. This suggests that targeting the PD-1/PD-L1 pathway could represent a new potential therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thibault Vieira, Martine Antoine, Cécile Hamard, Vincent Fallet, Michael Duruisseaux, Nathalie Rabbe, Anita Rodenas, Jacques Cadranel, Marie Wislez,